References
Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A (2017) International trends in anal cancer incidence rates. Int J Epidemiol 46:924–938
Prezzi D, Muthuswamy K, Ashik Amlani A et al (2023) Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma. Eur Radiol. https://doi.org/10.1007/s00330-023-09942-0
Kochhar R, Renehan AG, Mullan D, Chakrabarty B, Saunders MP, Carrington BM (2017) The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer. Eur Radiol 27:607–617
Rao S, Guren MG, Khan K et al (2021) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(9):1087–1100
Gourtsoyianni S, Goh V (2014) MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdom Imaging 39:2–17
Adusumilli P, Elsayed N, Theophanous S et al (2022) Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy. Eur Radiol 32(8):5086–5096
Beets-Tan RGH, Lambregts DMJ, Maas M et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465–1475
van Griethuysen JJM, Bus EM, Hauptmann M et al (2018) Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 1.5 T - effect of applying a micro-enema to improve image quality. Eur J Radiol 99:131–137
Glynne-Jones R, Sebag-Montefiore D, Meadows HM et al (2017) Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. Lancet Oncol 18(3):347–356
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Kirsten L. Gormly.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Not applicable.
Ethical approval
Institutional review board approval was not required because it is a commentary.
Study subjects or cohorts overlap
Not applicable.
Methodology
• Not applicable.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1007/s00330-023-09942-0.
Rights and permissions
About this article
Cite this article
Gormly, K.L. Anal cancer MRI: DWI assists response assessment for squamous cell carcinoma, but achieving widespread high-quality scans remains challenging. Eur Radiol 33, 7573–7574 (2023). https://doi.org/10.1007/s00330-023-09970-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09970-w